(Q48932150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

main subject

hepatic encephalopathy

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Michele Malaguarnera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Massimo Motta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Maria Giordano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Giulia Malaguarnera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Rita Bella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Giuseppe Nunnari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Liborio Rampello

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Giovanni Pennisi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

26 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

published in

Metabolic Brain Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

281-289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11011-011-9260-z

11 February 2020

exact match

0 references

cites work

Loss of expression of glial fibrillary acidic protein in acute hyperammonemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Pathophysiology of hepatic encephalopathy: a new look at ammonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Ammonia: key factor in the pathogenesis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Increased "peripheral-type" benzodiazepine receptor sites and mRNA in thalamus of thiamine-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

L-carnitine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Role of carnitine in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Pathogenetic mechanisms of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Effects of L-carnitine in patients with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Acetyl-L-carnitine treatment in minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Comparison of the effects of L-carnitine, D-carnitine and acetyl-L-carnitine on the neurotoxicity of ammonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Hyperammonemia causes altered protein phosphorylation in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Carnitine: an osmolyte that plays a metabolic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Differential inhibition by hyperammonemia of the electron transport chain enzymes in synaptosomes and non-synaptic mitochondria in ornithine transcarbamylase-deficient spf-mice: restoration by acetyl-L-carnitine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-L-carnitine in restoring the ammonia-induced cerebral energy depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Long-term acetyl-L-carnitine treatment in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Quantitative EEG analysis and survival in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

Role of carnitine esters in brain neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-011-9260-Z

World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects

21 January 2018

1 reference

12 December 2020

Morphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studies

1 reference

12 December 2020

Neurotoxicity of ammonia and glutamate: molecular mechanisms and prevention.

1 reference

12 December 2020

Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.

1 reference

12 December 2020

Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.

1 reference

12 December 2020

Carnitine--metabolism and functions

1 reference

12 December 2020

Effects of l-Acetylcarnitine on Cirrhotic Patients with Hepatic Coma: Randomized Double-Blind, Placebo-Controlled Trial

1 reference

12 December 2020

[Direct determination of plasma ammonia without deproteinization. An improved enzymic determination of ammonia, II (author's transl)]

1 reference

12 December 2020

L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.

1 reference

12 December 2020

Neurochemical aspects of aging in primates

1 reference

12 December 2020

Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box?

1 reference

12 December 2020

Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.

1 reference

12 December 2020

Neuropsychological assessment

1 reference

12 December 2020

10.1007/S11011-011-9260-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21870121%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference